1 – 13 of 13
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Point-of-care biomarkers in asthma management : Time to move forward
(
- Contribution to journal › Debate/Note/Editorial
- 2019
-
Mark
Association of elevated fractional exhaled nitric oxide concentration and blood eosinophil count with severe asthma exacerbations
(
- Contribution to journal › Article
-
Mark
The REal Life EVidence AssessmeNt Tool (RELEVANT) : Development of a novel quality assurance asset to rate observational comparative effectiveness research studies
(
- Contribution to journal › Article
-
Mark
Quality standards in respiratory real-life effectiveness research : The REal Life EVidence AssessmeNt Tool (RELEVANT): Report from the Respiratory Effectiveness Group - European Academy of Allergy and Clinical Immunology Task Force
(
- Contribution to journal › Article
-
Mark
Prevalence and characteristics of asthma-chronic obstructive pulmonary disease overlap in routine primary care practices
(
- Contribution to journal › Article
- 2018
-
Mark
Real-world effectiveness evaluation of budesonide/formoterol Spiromax for the management of asthma and chronic obstructive pulmonary disease in the UK
(
- Contribution to journal › Article
-
Mark
Chronic obstructive pulmonary disease guidelines in Europe : A look into the future
(
- Contribution to journal › Scientific review
-
Mark
Inhaler technique mastery and maintenance in healthcare professionals trained on different devices
(
- Contribution to journal › Article
- 2017
-
Mark
Indacaterol/glycopyrronium is cost-effective compared to salmeterol/fluticasone in COPD : FLAME-based modelling in a Swedish population
(
- Contribution to journal › Article
-
Mark
European Respiratory Society statement : Diagnosis and treatment of pulmonary disease in α1-antitrypsin deficiency
(
- Contribution to journal › Article
- 2016
-
Mark
The Relationship Between 24-Hour Symptoms and COPD Exacerbations and Healthcare Resource Use : Results from an Observational Study (ASSESS)
(
- Contribution to journal › Article
- 2014
-
Mark
Current evidence and future research needs for FeNO measurement in respiratory diseases.
(
- Contribution to journal › Scientific review
-
Mark
lObservational study to characterise 24-hour COPD symptoms and their relationship with patient-reported outcomes: results from the ASSESS study
(
- Contribution to journal › Article